GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

116 calculators match

Most used

21
MELD-NaAssesses the severity of chronic liver diseaseChild-Pugh ScoreAssesses the prognosis of chronic liver disease, mainly cirrhosisFIB-4 IndexLiver fibrosis scoring indexAPRIAST to platelet ratio — liver fibrosisMaddrey's DFAlcoholic hepatitis severityGlasgow-BlatchfordUpper GI bleed risk stratificationGAHSGlasgow alcoholic hepatitis scoreMontreal IBDIBD classification — CD & UCMayo ScoreUlcerative colitis activityBISAP ScoreBedside index for severity of pancreatitisCLIF-SOFAOrgan failure scoring in cirrhosisAlcohol ContentStandard drinks & alcohol grams calculatorAARC-ACLFAcute-on-chronic liver failure gradePELD / CR ScorePediatric end-stage liver diseaseHarvey-BradshawCrohn's disease activity indexCTSICT severity index — pancreatitisRockall ScoreGI bleed rebleeding & mortality riskCAGEAlcohol use disorder screening (4 questions)MELD 3.0Updated MELD — sex-inclusive formulaAUDIT ScoreAlcohol use disorders identification testVOCAL-Penn ScorePost-operative mortality risk in cirrhosis surgery

Liver & Cirrhosis

17
ALBI GradeAlbumin-bilirubin liver function grade in HCCUKELD ScoreUK model for end-stage liver diseaseMELD-XIMELD excluding INR — for anticoagulated patientsWest Haven CriteriaHepatic encephalopathy gradingMilan CriteriaLiver transplant eligibility in hepatocellular carcinomaLI-RADS v2018 (CT/MRI)Liver observation category from size, APHE and major featuresBCLC StagingHepatocellular carcinoma stage and treatment allocationSimplified AIH CriteriaSimplified criteria for autoimmune hepatitisRevised Original AIH ScoreIAIHG 1999 comprehensive autoimmune hepatitis scoreSAAGSerum-ascites albumin gradient — cause of ascitesR FactorHepatocellular vs cholestatic pattern in liver injuryCLIF-C ACLFMortality prediction in acute-on-chronic liver failureKing's College CriteriaTransplant criteria in acute liver failureGALAD ScoreHCC detection from gender, age, AFP-L3, AFP and DCPMetroticket 2.0AFP-adjusted up-to-seven for HCC transplant eligibilityRUCAMCausality in drug- and herb-induced liver injuryBaveno VII CriteriacACLD, CSPH and sparing screening endoscopy

Fibrosis & MASLD

8
NAFLD Fibrosis ScoreAdvanced fibrosis probability in MASLD/NAFLDBARD ScoreBMI, AST/ALT ratio, diabetes — MASLD fibrosisFatty Liver IndexPredicts hepatic steatosis from routine labsFibrotic NASH Index (FNI)At-risk NASH probability from AST, HbA1c and HDLNAFLD Activity Score (NAS)Histologic activity grade — steatosis, inflammation, ballooningMEFIB IndexMRE + FIB-4 rule for significant fibrosis (≥F2) in MASLDFAST ScoreFibroScan-AST — at-risk NASH from LSM, CAP and ASTSAFE ScoreSteatosis-Associated Fibrosis Estimator for MASLD in primary care

Pancreas & Biliary

8
Ranson's CriteriaAcute pancreatitis severity at 48 hoursGlasgow-Imrie CriteriaAcute pancreatitis severity — the PANCREAS criteriaHAPSHarmless acute pancreatitis scoreTokyo Guidelines — CholangitisTG18 diagnosis and severity grade for acute cholangitisTokyo Guidelines — CholecystitisTG18 diagnosis and severity grade for acute cholecystitisBiliary Pain (Rome IV)Rome IV — defining biliary-type pain before interventionFunctional Pancreatic SODRome IV — pancreatic sphincter of Oddi disorderRevised Atlanta ClassificationAcute pancreatitis severity — mild, moderately severe, severe

IBD

9
Truelove & Witts CriteriaAcute severe ulcerative colitis — admission decisionUCEISUlcerative colitis endoscopic index of severitySCCAISimple clinical colitis activity index — symptoms onlyCDAICrohn's disease activity index — the trial standardSES-CDEndoscopic severity in Crohn's diseasePUCAIPaediatric ulcerative colitis activity indexTravis (Oxford) CriteriaDay 3 colectomy risk in acute severe ulcerative colitisHo IndexDay 3 steroid failure risk in acute severe ulcerative colitisRutgeerts ScorePostoperative Crohn's recurrence at ileocolonoscopy

GI Bleeding

7
EVendo ScorePredicts oesophageal varices needing treatmentForrest ClassificationPeptic ulcer bleeding — rebleeding risk at endoscopyAIMS65 ScoreUpper GI bleed mortality — five bedside criteriaOakland ScoreSafe-discharge risk for acute lower GI bleedingABC ScoreAge, blood tests, comorbidities — GI bleed mortalitySarin ClassificationEndoscopic classification of gastric varicesEGUS (Gastric Ulcer)Malignancy risk in a gastric ulcer, and who needs repeat endoscopy

Alcohol

2
ABIC ScoreAge, bilirubin, INR, creatinine — alcoholic hepatitisLille ModelSteroid response at day 7 in alcoholic hepatitis

Upper GI

4
Chicago Classification v4.0Oesophageal motility pattern from high-resolution manometryLA Classification (Oesophagitis)Los Angeles grade A–D for erosive oesophagitisPrague C & M CriteriaCircumferential and maximal extent of Barrett's oesophagusEREFS (Eosinophilic Oesophagitis)Endoscopic reference score — oedema, rings, exudates, furrows, stricture

Colorectal

3
Boston Bowel Prep ScaleColonoscopy preparation adequacy by segmentStool Osmotic GapOsmotic vs secretory diarrhoea from stool electrolytesATLAS Score (C. difficile)Predicted response to therapy in Clostridioides difficile infection

Functional GI

37
Bristol Stool ScaleStool form types 1–7 and colonic transitRome IV Criteria for IBSIrritable bowel syndrome diagnosis and subtypeFunctional ConstipationRome IV — two of six items, IBS excludedOpioid-Induced ConstipationRome IV — constipation tied to opioid therapyFunctional DiarrhoeaRome IV — loose stools without predominant painFunctional Bloating / DistensionRome IV — bloating without other bowel disorder criteriaUnspecified Functional Bowel DisorderRome IV — bowel symptoms fitting no other categoryCentrally Mediated Abdominal Pain (CAPS)Rome IV — continuous pain unrelated to gut eventsNarcotic Bowel SyndromeRome IV — opioid-induced hyperalgesia of the gutFaecal Incontinence (Rome IV)Rome IV — the criteria, and why nobody is askedFunctional Anorectal PainLevator ani, unspecified pain and proctalgia fugaxFunctional Defecation DisordersRome IV — dyssynergia and inadequate propulsionInfant RegurgitationRome IV — the happy spitter, and the alarm features that rule it outInfant ColicRome IV — recurrent unexplained crying in a well infant under 5 monthsInfant DyscheziaRome IV — straining before a soft stool, and why not to intervenePaediatric Functional ConstipationRome IV — two of six over one month, with overflow soiling as a criterionToddler's DiarrhoeaRome IV functional diarrhoea of childhood — painless, thriving childPaediatric Cyclic Vomiting SyndromeRome IV — both age bands, with different criteria for eachPaediatric Rumination SyndromeRome IV — infant and child/adolescent criteriaFunctional Nausea & Vomiting (Children)Rome IV — two separate disorders that can be met togetherAerophagiaRome IV — distension that increases through the dayPaediatric Functional DyspepsiaRome IV — four times a month, with PDS and EPS subtypingPaediatric Irritable Bowel SyndromeRome IV — plus the constipation clause clinicians missAbdominal MigraineRome IV — stereotypical incapacitating episodes weeks apartFunctional Abdominal Pain — NOSRome IV — the residual category, reached after the other threeNonretentive Faecal IncontinenceRome IV — soiling without retention, where laxatives make it worseFunctional DyspepsiaRome IV — with PDS and EPS subtypingRumination SyndromeRome IV — effortless regurgitation without retchingCyclic Vomiting SyndromeRome IV — stereotypical episodic vomitingCannabinoid HyperemesisRome IV — CVS pattern relieved by cannabis cessationChronic Nausea & VomitingRome IV — chronic nausea and vomiting syndromeBelching DisordersRome IV — supragastric vs gastric belchingFunctional HeartburnRome IV — heartburn with normal acid exposureReflux HypersensitivityRome IV — normal acid exposure, positive symptom associationFunctional Chest PainRome IV — non-cardiac, non-reflux chest painGlobusRome IV — painless lump-in-throat sensationFunctional DysphagiaRome IV — dysphagia with normal endoscopy and manometry
  1. Calculators
  2. /
  3. Paediatric Functional Constipation
Functional GI

Paediatric Functional Constipation

Rome IV — two of six over one month, with overflow soiling as a criterion

The item lists differ between the two Rome IV chapters, and the child/adolescent version adds an explicit IBS exclusion and a frequency rule.

One month in both bands, against three months in the adult criteria.

The child/adolescent criteria add this frequency requirement; the infant criteria do not.

Stated explicitly in H3a. A child whose pain resolves with the constipation has functional constipation; one whose pain persists has IBS.

Two of the listed items, one month — far shorter than the adult three months. Rome IV shortened it because withholding treatment from a constipated child for a qualifying period causes harm.

When to use
Use it for any child presenting with infrequent, painful or difficult defecation, and use it especially for the child presenting with soiling — because faecal incontinence in a constipated child is overflow around a retained mass, and it is routinely misread as behavioural. Functional constipation accounts for the overwhelming majority of childhood constipation, so this is a diagnosis to make positively at the first consultation rather than one to arrive at after investigation. It applies across two age bands with slightly different item lists: infants and toddlers up to four years, and children and adolescents from a developmental age of four.
Why use it
Because the two things clinicians most often get wrong here are both encoded in the criteria. The first is soiling: listing faecal incontinence as a diagnostic item for constipation makes explicit that overflow is a sign of retention, not of defiance or regression, which changes both the treatment and the way the family is spoken to. The second is the timeline. Rome III required two months; Rome IV halved it to one, and did so on the reasoning that a child who is withholding is establishing a cycle that becomes harder to break the longer it runs. A qualifying period exists to prevent overdiagnosis, but in a condition where delay is itself harmful, a long one causes more damage than it prevents. Using the criteria as written means treating a month earlier than the previous edition allowed.
Formula, evidence and interpretation

About the Rome IV Criteria for Paediatric Functional Constipation

Two of six, held for one month. In children of developmental age four years and over the six items are: two or fewer defecations in the toilet per week; at least one episode of faecal incontinence per week; retentive posturing or excessive volitional stool withholding; painful or hard bowel movements; a large faecal mass in the rectum; and large-diameter stools that can block the toilet. The child/adolescent version adds three gates the infant version does not — the items must occur at least weekly, criteria for irritable bowel syndrome must be insufficient, and other conditions must have been excluded. One month is the qualifying period, not the three months the adult criteria require, and that difference is deliberate.

On this page

  • Formula
  • Interpreting the result
  • Inputs
  • What it returns
  • How it is calculated
  • Facts & figures
  • Evidence
  • How it compares
  • Pearls & pitfalls
  • Critical actions
  • Why it exists
  • About the creator
  • Limitations
  • If you are the patient
  • FAQ
  • Related calculators
  • References

Formula

Infant / toddler (G7) = ≥ 2 of 7 items AND duration ≥ 1 month Child / adolescent (H3a) = ≥ 2 of 6 items AND duration ≥ 1 month AND items occur at least once per week AND insufficient criteria for irritable bowel syndrome AND not fully explained by another medical condition
Two of the listed items
A count, not a weighting. No item carries more diagnostic weight than another, although a large faecal mass and toilet-blocking stools are the most specific in practice.
One month
Halved from Rome III's two months. The reasoning was that the retention cycle self-reinforces, so a long qualifying period delays treatment at exactly the point where it is most effective.
Developmental age ≥ 4 years
Developmental, not chronological. A child with global developmental delay is assessed against the infant criteria regardless of birthday.
Insufficient criteria for IBS
Present only in H3a. Where abdominal pain resolves as the constipation is treated, this is functional constipation; where pain persists independently, it is IBS with constipation.
  • One month in both paediatric bands, against three months in the adult functional constipation criteria.
  • Rome III required two months; Rome IV halved it and removed the requirement for the child to be at least four years old for the older criteria to apply.
  • 'In the toilet' qualifies the frequency item in H3a but not in G7.
  • A rectal examination is not required by the criteria and is not needed in most children.

Interpreting the result

Meeting criteria means starting treatment, and treatment has two phases that must not be collapsed into one. Disimpaction comes first where there is a significant faecal mass, using high-dose oral polyethylene glycol; skipping it and going straight to a maintenance dose is the commonest cause of apparent treatment failure, because a maintenance dose cannot shift an established impaction and the soiling continues while the family loses confidence. Maintenance follows, and it needs to be prolonged — months at minimum, often longer, with the dose titrated to soft stool rather than to a fixed prescription. Stopping as soon as things improve is the second commonest cause of failure. Alongside the drug, the behavioural component needs addressing: unhurried toilet sitting after meals to exploit the gastrocolic response, adequate foot support so the child can generate abdominal pressure, and a reward system oriented towards sitting rather than towards producing a stool. Explain to the family and, in age-appropriate terms, to the child that soiling is involuntary. Where criteria are not met, or where alarm features are present, the picture changes: delayed passage of meconium beyond forty-eight hours, ribbon stools, failure to thrive, bilious vomiting, abdominal distension, an abnormal anal position or tone, a sacral dimple or tuft, or a lower-limb neurological abnormality all point away from functional constipation and towards Hirschsprung disease, a spinal cord anomaly, hypothyroidism, coeliac disease or an anorectal malformation.

ScoreBandWhat it meansAction
≥ 2 items, ≥ 1 month (with band gates satisfied)Functional constipationRome IV criteria met — functional constipation is the diagnosis in the great majority of constipated childrenDisimpact if a mass is present, then prolonged maintenance polyethylene glycol plus toileting behaviour work
≥ 2 items with faecal incontinence presentFunctional constipation with overflow incontinenceRetention advanced enough that stool is tracking around an impacted massDisimpaction is essential before maintenance; state explicitly to family and child that the soiling is involuntary
≥ 2 items but IBS criteria also satisfied (H3a)Consider IBS with constipationAbdominal pain that does not resolve as the constipation is treatedAssess against the paediatric IBS criteria; treatment differs beyond laxatives alone
Criteria not met, or alarm features presentNot functional constipationDelayed meconium, ribbon stools, faltering growth, distension, or abnormal spine or neurological examinationInvestigate for Hirschsprung disease, spinal anomaly, hypothyroidism, coeliac disease or anorectal malformation

What the Paediatric Functional Constipation needs (7 inputs)

Two or fewer defecations in the toilet per week (developmental age ≥ 4 years)
The child/adolescent wording specifies 'in the toilet', which matters — a child passing stool into underwear several times a day can still satisfy this item, and frequently does. The infant list simply reads two or fewer defecations per week.
At least one episode of faecal incontinence per week
Overflow soiling around a retained mass. Its presence on a constipation item list is the single most useful teaching point in these criteria. In the infant list this item applies only after toileting skills have been acquired.
History of retentive posturing or excessive volitional stool retention
Stiffening, crossing the legs, standing on tiptoe, hiding, or clenching the buttocks. Families almost always describe this as straining to push, which is the opposite of what is happening, so it needs asking about specifically.
History of painful or hard bowel movements
Pain is the engine of the whole cycle. One painful stool teaches a child to withhold, withholding hardens the next stool, and the next one hurts more.
Presence of a large faecal mass in the rectum
Established by abdominal palpation, or by rectal examination where that is justified. Rome IV does not require a rectal examination, and in most children the diagnosis can be made without one.
History of large diameter stools which can obstruct the toilet
A concrete question families answer reliably — 'have you ever had to break it up or has it blocked the toilet' — and one that identifies a megarectum without any examination.
Gates applying to the child/adolescent band only: weekly frequency, insufficient IBS criteria, and other conditions excluded
Three additional requirements in H3a that the infant criteria (G7) do not carry. The IBS exclusion is the one that changes management most often.

What it returns

Criteria met or not met
Two or more items, plus the one-month duration and, in the older band, the three additional gates.
How many items are satisfied
Reported explicitly. The count is not a severity score, but it does show how close a child sits to the threshold.
Which age band's criteria were applied
G7 for infants and toddlers up to four years, H3a for children of developmental age four and above.

How it is calculated

Functional constipation in childhood is a behavioural cycle built on a physiological substrate, and the criteria are constructed around that cycle rather than around transit measurements. It begins with one hard or painful stool — often at a transition point such as weaning, toilet training, starting school, or an illness with reduced intake. The child learns that defecation hurts and begins to withhold, which is an active process involving contraction of the pelvic floor and external sphincter against the urge, and which families consistently mistake for straining. Withheld stool sits in the rectum, water continues to be reabsorbed, and the mass becomes larger and harder, so the next passage is more painful than the last. Over weeks the rectum accommodates to the enlarged volume, sensation of the urge diminishes, and the child stops registering the need to go at all. At that point looser stool from above begins to track around the impacted mass and leaks without the child's awareness, which is what presents as soiling. The child genuinely does not feel it happening, and the frequent assumption that they must have noticed is both wrong and damaging. Each element of the criteria maps onto a stage of this sequence: painful stools at the start, retentive posturing in the middle, large-diameter stools and a palpable mass once the rectum has stretched, and incontinence at the end.

Facts & figures

Where the two age bands differ
RequirementInfant / toddler (G7)Child / adolescent (H3a)
Items required2 of 72 of 6
Duration1 month1 month
Items must occur weeklyNoYes
IBS exclusion statedNoYes
Other conditions excludedNot stated explicitlyYes
Frequency item wordingTwo or fewer defecations per weekTwo or fewer defecations in the toilet per week
Incontinence itemApplies only after toileting skills acquiredAt least one episode per week, unconditional
Age basisUp to 4 yearsDevelopmental age ≥ 4 years

The 'in the toilet' qualifier in H3a is easy to overlook and materially changes who qualifies — a child soiling daily but rarely producing a stool in the toilet satisfies the frequency item.

The two commonest reasons treatment appears to fail
ErrorWhat happensCorrection
Maintenance without disimpactionA maintenance dose cannot clear an established mass; soiling continues and the family concludes laxatives do not workDisimpact first with high-dose oral polyethylene glycol, then step down
Stopping maintenance too earlyThe rectum has not recovered its calibre or sensation; retention restarts within weeksContinue for months, titrated to soft stool, and wean slowly rather than stopping

Both errors are about duration and dose rather than drug choice, which is why switching agents rarely helps.

Evidence

Derivation — Rome Foundation paediatric committees

2016

Consensus criteria from the Rome IV committees on childhood functional gastrointestinal disorders, published in Gastroenterology in 2016 as separate neonate/toddler and child/adolescent chapters.

Consensus-derived. The substantive changes from Rome III were halving the duration requirement from two months to one, and removing the requirement that a child be at least four years old before the older criteria could be applied.

Guideline — ESPGHAN / NASPGHAN evidence-based recommendations

2014

Joint evidence-based guideline on the evaluation and treatment of functional constipation in infants and children, developed by ESPGHAN and NASPGHAN.

Recommends polyethylene glycol as first-line for both disimpaction and maintenance, and advises against routine radiography and routine rectal examination in children meeting clinical criteria.

How it compares

Paediatric Functional Constipation vs Non-retentive faecal incontinence

The presence or absence of retention decides it, and getting it wrong means giving laxatives to a child who has no stool to shift.

Both present with a school-aged child soiling their underwear, and the distinction cannot be made from the soiling alone. Functional constipation with overflow comes with the retention features — infrequent defecation, painful or large stools, withholding behaviour, a palpable mass. Non-retentive faecal incontinence has none of them: stool frequency and consistency are normal and there is no retention, which Rome IV requires to be absent. The treatments diverge completely. Laxatives are the mainstay of one and are useless in the other, where the work is behavioural and often psychological. Where a child has been on escalating laxative doses without improvement and never had a demonstrable mass, this is the diagnosis to revisit.

Open the Non-retentive faecal incontinence calculator →

Paediatric Functional Constipation vs Paediatric irritable bowel syndrome

Rome IV settles the overlap explicitly — H3a requires that criteria for IBS are insufficient, so IBS takes precedence when both could apply.

A constipated child with abdominal pain could plausibly be given either label, and Rome IV resolves it by building the exclusion into the constipation criteria rather than leaving it to judgement. The practical discriminator is what happens to the pain during treatment: where it resolves as the constipation is cleared, functional constipation was the diagnosis; where it persists independently of stool frequency and consistency, IBS with constipation fits better. That distinction matters because IBS brings interventions beyond laxatives, and because continuing to escalate laxatives against pain that is not retention-driven achieves nothing.

Open the Paediatric irritable bowel syndrome calculator →

Paediatric Functional Constipation vs Hirschsprung disease

The organic diagnosis these criteria must never mask, and the discriminators are almost all historical or on examination rather than in the stool pattern.

Hirschsprung disease is far less common than functional constipation but is the consequence of getting this wrong. The features that separate it are delayed passage of meconium beyond forty-eight hours, onset in the neonatal period rather than around a transition such as toilet training, ribbon-like stools, abdominal distension, faltering growth, absent withholding behaviour, absent soiling, and an empty rectum with a tight anal canal on examination. Functional constipation characteristically starts later, involves active withholding, produces large stools rather than narrow ones, and is associated with overflow soiling. Where the history points to the neonatal period, or where the child has never had a comfortable pattern to return to, referral for rectal biopsy is appropriate rather than a further laxative trial.

Pearls & pitfalls

  • Soiling is overflow, not behaviour. It is on the item list for constipation precisely because it is so often managed as a behavioural problem instead.
  • The child cannot feel the soiling happening. Saying this explicitly to the family, in front of the child, changes the dynamic more than any prescription.
  • Retentive posturing looks like straining. Families describe a child pushing; ask specifically about stiffening, leg-crossing, tiptoeing and hiding.
  • Disimpact before maintaining. A maintenance dose will not clear an established mass, and the resulting 'failure' costs the family's confidence.
  • Treat for months, not weeks, and wean rather than stop. Early cessation is the commonest cause of relapse.
  • One month, not three. Applying the adult duration rule delays treatment during the period when it works best.
  • 'In the toilet' qualifies the frequency item in the older band — a child soiling daily may still meet it.
  • Developmental age, not chronological age, decides which item list applies.
  • A rectal examination is not required by the criteria and is not needed in most children; abdominal palpation and the toilet-blocking question usually suffice.
  • Delayed meconium beyond forty-eight hours, ribbon stools or an abnormal sacrum move this out of functional territory — check the back and the anal position.
  • In the older band, ask whether pain resolves as constipation is treated. Persistent independent pain points to IBS rather than functional constipation.

Critical actions

  • Establish stool frequency, consistency and calibre, and ask directly whether stools have ever blocked the toilet.
  • Ask specifically about withholding behaviours rather than about straining.
  • Ask about soiling explicitly — families frequently do not volunteer it and children rarely do.
  • Palpate the abdomen for a faecal mass; reserve rectal examination for cases where the diagnosis is genuinely uncertain.
  • Examine the lumbosacral spine, anal position and tone, and lower-limb neurology.
  • Confirm meconium was passed within forty-eight hours of birth.
  • Plot growth — faltering growth is not a feature of functional constipation.
  • Disimpact with high-dose oral polyethylene glycol where a mass is present, before starting maintenance.
  • Prescribe maintenance polyethylene glycol titrated to soft stool, and set the expectation of months of treatment at the outset.
  • Set up unhurried post-meal toilet sitting with proper foot support, and reward sitting rather than stool production.
  • State to the family and the child that the soiling is involuntary.
  • Arrange planned review rather than as-required follow-up, and use it to check adherence and titrate rather than to stop.

Why this score exists

Halving the duration requirement is the most consequential thing Rome IV did to this definition, and the rationale is worth stating because it inverts the usual logic of diagnostic criteria. Qualifying periods normally exist to protect against overdiagnosis — wait long enough and self-limiting problems declare themselves. The paediatric committees judged that constipation does not behave that way in children. Withholding is self-reinforcing: each retained stool enlarges and hardens the next, the rectum accommodates, sensation is lost, and by the time a two-month threshold has elapsed a child who could have been treated with a short course of laxative may need disimpaction and months of maintenance. The committee concluded that the harm of waiting exceeded the harm of treating a child who might have resolved anyway, and shortened the period accordingly. Keeping faecal incontinence on the item list reflects the same instinct — naming overflow as a feature of constipation rather than a separate behavioural problem is what stops it being managed as one.

About the creator

  • Jeffrey S. Hyams

    First author, Rome IV child/adolescent functional gastrointestinal disorders committee

    Led the committee producing the child and adolescent criteria (H3a).

  • Marc A. Benninga

    First author, Rome IV neonate/toddler functional gastrointestinal disorders committee

    Led the committee producing the infant and toddler criteria (G7), and has published extensively on childhood constipation.

  • Carlo Di Lorenzo

    Co-author; paediatric neurogastroenterology and motility

    Contributed to the child and adolescent chapter of Rome IV.

Limitations

  • Consensus criteria with no external validation, and the two-of-six threshold is a convention rather than a derived cut-off.
  • No severity grading, so a child with mild infrequency and one with a megarectum and daily overflow receive the same diagnosis.
  • 'Large diameter' and 'large faecal mass' are not quantified and depend on the observer.
  • The one-month duration was shortened on reasoning rather than on trial evidence comparing outcomes at one versus two months.
  • Dependent on caregiver report for most items, and soiling in particular is under-reported through embarrassment.
  • The infant criteria do not state an exclusion for other medical conditions, although one is clearly intended.
  • Nothing in the criteria distinguishes a child in the early withholding phase from one with an established megarectum, though the treatment burden differs greatly.
  • The IBS exclusion appears only in the older band, leaving the overlap unaddressed in toddlers.
  • No guidance on when failure to respond should prompt investigation rather than dose escalation.

If you are the patient

Functional constipation means a child who does not empty their bowels often enough or comfortably enough, and where there is no underlying disease causing it — which is true for almost every constipated child. It usually starts with one stool that hurt. That is enough to teach a child, quite sensibly, to avoid doing it again, and they begin holding on. You may see this as stiffening, crossing legs, going up on tiptoe, hiding in a corner or going very still — it often looks like pushing, but it is the opposite. The problem is that held-on stool gets bigger and harder while it waits, so the next one hurts more, and the cycle tightens. If this continues, the lower bowel stretches and the child stops feeling the urge at all. At that stage softer stool from higher up leaks around the hard lump, and this is the soiling that many families see. The most important thing to understand is that your child cannot feel this happening and is not doing it deliberately. It is not laziness, naughtiness or going backwards, and telling them off for it will not help and will make them more ashamed. Treatment usually means a medicine called polyethylene glycol (macrogol). If there is a hard lump to clear, a higher dose is used first for a few days — this is called disimpaction, and it can make the soiling worse briefly before it gets better. After that a smaller daily dose keeps things soft. Two things matter more than which medicine is used: clearing the lump before starting the regular dose, and carrying on with the regular dose for months rather than weeks. Stopping as soon as things look better is the usual reason the problem comes back. Alongside the medicine, sitting on the toilet unhurried for a few minutes after meals helps, and so does a footstool so your child can push properly. Reward the sitting, not the result.

Frequently asked questions

What are the Rome IV criteria for functional constipation in children?#

In children of developmental age four and over, two or more of: two or fewer defecations in the toilet per week; at least one episode of faecal incontinence per week; retentive posturing or excessive volitional stool retention; painful or hard bowel movements; a large faecal mass in the rectum; and large-diameter stools that can obstruct the toilet. These must be present for at least one month, occur at least weekly, with insufficient criteria for irritable bowel syndrome and no other explanation. Infants and toddlers up to four use a similar seven-item list without the weekly, IBS and exclusion gates.

Why is the duration one month rather than three?#

Because withholding is self-reinforcing. Each retained stool becomes larger and harder, so the next is more painful, and over time the rectum stretches and the child loses the sensation of needing to go. Rome IV halved the Rome III requirement from two months on the reasoning that a long qualifying period delays treatment precisely when it is most effective and least burdensome. The adult criteria still use three months.

Why is soiling listed as a sign of constipation?#

Because it usually is one. When a hard mass sits in the rectum, softer stool from above tracks around it and leaks without the child noticing, since the stretched rectum no longer signals. Listing faecal incontinence among the diagnostic items is Rome IV's way of stopping overflow being managed as a behavioural problem. The child genuinely cannot feel it happening, and saying so explicitly to the family is part of the treatment.

Is a rectal examination needed to make the diagnosis?#

Usually not. Rome IV does not require one, and the ESPGHAN/NASPGHAN guideline advises against performing it routinely in children who meet clinical criteria. Abdominal palpation for a faecal mass, together with the history — particularly whether stools have ever blocked the toilet — is generally sufficient. It is reserved for cases where the diagnosis is genuinely uncertain.

Why does treatment often seem to fail?#

Almost always for one of two reasons, and neither is the choice of drug. The first is starting maintenance without disimpacting: a maintenance dose cannot shift an established mass, so soiling continues and the family loses confidence in the treatment. The second is stopping too soon, before the rectum has recovered its calibre and sensation, which lets retention restart within weeks. Treatment should run for months, be titrated to soft stool, and be weaned rather than stopped.

What distinguishes this from non-retentive faecal incontinence?#

Retention. Functional constipation with overflow comes with infrequent, painful or large-calibre stools, withholding behaviour and often a palpable mass. Non-retentive faecal incontinence has normal stool frequency and consistency and no retention at all. The distinction is important because laxatives are central to one and useless in the other, where the work is behavioural.

What are the red flags that argue against a functional diagnosis?#

Delayed passage of meconium beyond forty-eight hours, onset in the neonatal period, ribbon-like stools, faltering growth, abdominal distension, bilious vomiting, an abnormal anal position or tone, a sacral dimple or hair tuft, and lower-limb neurological abnormality. These point towards Hirschsprung disease, a spinal cord anomaly or an anorectal malformation, and warrant investigation rather than a further laxative trial.

Does developmental delay change which criteria apply?#

Yes. The older item list applies from a developmental age of four years, not a chronological age of four. A child with global developmental delay is assessed against the infant and toddler criteria regardless of their birthday, which matters because that list omits the weekly-frequency, IBS and exclusion gates.

Related calculators

  • Nonretentive Faecal Incontinence — Rome IV — soiling without retention, where laxatives make it worse
  • Paediatric Irritable Bowel Syndrome — Rome IV — plus the constipation clause clinicians miss
  • Infant Dyschezia — Rome IV — straining before a soft stool, and why not to intervene
  • Functional Constipation — Rome IV — two of six items, IBS excluded
  • Toddler's Diarrhoea — Rome IV functional diarrhoea of childhood — painless, thriving child

References

Original / primary reference

  1. Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Childhood Functional Gastrointestinal Disorders: Child/Adolescent. Gastroenterology. 2016;150(6):1456-1468 (Rome IV).
  2. Benninga MA, Nurko S, Faure C, Hyman PE, St James Roberts I, Schechter NL. Childhood Functional Gastrointestinal Disorders: Neonate/Toddler. Gastroenterology. 2016;150(6):1443-1455 (Rome IV).

Guidelines

  1. Tabbers MM, DiLorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58(2):258-274.

Last updated August 1, 2026. Clinical knowledge base written and curated by GastroAGI Team from primary medical literature.

Written from primary literature and not yet independently clinically reviewed.

For use by qualified healthcare professionals. This calculator supports clinical judgement and does not replace it.